Literature DB >> 19035275

Expression of p16, p53 and Ki-67 proteins in the progression of epithelial dysplasia of the oral cavity.

Francesca Angiero1, Angiola Berenzi, Anna Benetti, Elisa Rossi, Rachele Del Sordo, Angelo Sidoni, Michele Stefani, Enrico Dessy.   

Abstract

BACKGROUND: The overexpression of the protein products of genes associated with the cell cycle tumour protein53 (p53), cyclin-dependent kinase inhibitor 2A (p16) and antigen identified by monoclonal antibody Ki-67 (Ki-67) is apparently of great significance. This study evaluated the immunohistochemical expression of these proteins in precancerous lesions and in carcinoma of the oral cavity.
MATERIALS AND METHODS: The nuclear expression of p53 and Ki-67 and nuclear and/or cytoplasmic expression of p16 protein was examined in 54 biopsy specimens from the oral cavity obtained over a period of 3 years. The samples included 18 cases of normal/hyperplastic mucosa, 25 cases of dysplasia and 11 cases of invasive squamous cell carcinoma. The specimens were grouped into three categories: 1 = no or mild dysplasia, 2 = moderate or severe dysplasia, and 3 = invasive carcinoma.
RESULTS: p16 was negative in all the group 1 specimens, while both p53 and Ki-67, when present, were limited to the cells of the basal layer. In the group 2 specimens, the number of p16-, p53-, and Ki-67-positive cells increased as the grade of dysplasia progressed. In group 3 (invasive carcinomas), p53 and p16 expression occurred respectively in 81.8% and 54.5% of cases, while Ki-67 was elevated in all the cases.
CONCLUSION: The expression of the cell-cycle proteins p16 and p53 in the dysplastic epithelium, in association with Ki-67, may represent significant markers to recognize evolution of precancerous disease in the oral cavity and to improve identification of the degree of dysplasia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19035275

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

Review 1.  Tongue Lumps and Bumps: Histopathological Dilemmas and Clues for Diagnosis.

Authors:  Irit Allon; Marilena Vered; Ilana Kaplan
Journal:  Head Neck Pathol       Date:  2019-01-29

2.  Molecular Analysis as a Guide to Determining the Extent and Pathophysiology of Perilesional Tissues in Oral Epithelial Dysplasias.

Authors:  Meenakshi Singhal; Ankita Tandon; Saurabh Juneja; Devi Charan Shetty; Sanjeev Kumar; Anshi Jain
Journal:  J Maxillofac Oral Surg       Date:  2019-11-11

Review 3.  Oncoapoptotic markers in oral cancer: prognostics and therapeutic perspective.

Authors:  Anubhav Jain; Saurabh Bundela; Ram P Tiwari; Prakash S Bisen
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

4.  Multiple pathway-based genetic variations associated with tobacco related multiple primary neoplasms.

Authors:  Ashwin Kotnis; Junghyun Namkung; Sadhana Kannan; Nallala Jayakrupakar; Taesung Park; Rajiv Sarin; Rita Mulherkar
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

5.  FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.

Authors:  Muy-Teck Teh; Emilios Gemenetzidis; Deeviyaben Patel; Rameez Tariq; Ayesha Nadir; Adiam W Bahta; Ahmad Waseem; Iain L Hutchison
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

6.  Estimation of malignant transformation rate in cases of oral epithelial dysplasia and lichen planus using immunohistochemical expression of Ki-67, p53, BCL-2, and BAX markers.

Authors:  G Shailaja; J Vijay Kumar; P V Baghirath; U Kumar; G Ashalata; A Bhargavi Krishna
Journal:  Dent Res J (Isfahan)       Date:  2015 May-Jun

7.  Tumourigenesis driven by the human papillomavirus type 16 Asian-American e6 variant in a three-dimensional keratinocyte model.

Authors:  Robert Jackson; Melissa Togtema; Paul F Lambert; Ingeborg Zehbe
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

8.  Recurrence in Oral Premalignancy: Clinicopathologic and Immunohistochemical Analysis.

Authors:  Maria Georgaki; Dimitris Avgoustidis; Vasileios Ionas Theofilou; Evangelia Piperi; Efstathios Pettas; Demos G Kalyvas; Dimitrios Vlachodimitropoulos; Christos Perisanidis; Andreas C Lazaris; Nikolaos G Nikitakis
Journal:  Diagnostics (Basel)       Date:  2021-05-12

9.  Stromal p16 expression is significantly increased in malignant ovarian neoplasms.

Authors:  Nara Yoon; Gun Yoon; Cheol Keun Park; Hyun-Soo Kim
Journal:  Oncotarget       Date:  2016-10-04

10.  Keratoacanthoma of the Lip: Activation of the mTOR Pathway, Tumor Suppressor Proteins, and Tumor Senescence.

Authors:  Caroline Siviero Dillenburg; Manoela Domingues Martins; Luise Meurer; Rogerio Moraes Castilho; Cristiane Helena Squarize
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.